These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21617088)

  • 1. Active vitamin D and acute respiratory infections in dialysis patients.
    Tsujimoto Y; Tahara H; Shoji T; Emoto M; Koyama H; Ishimura E; Tabata T; Nishizawa Y; Inaba M
    Clin J Am Soc Nephrol; 2011 Jun; 6(6):1361-7. PubMed ID: 21617088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of oral versus intravenous vitamin D receptor activator in reducing infection-related mortality in hemodialysis patients: the Q-Cohort Study.
    Tanaka S; Ninomiya T; Taniguchi M; Fujisaki K; Tokumoto M; Hirakata H; Ooboshi H; Kitazono T; Tsuruya K
    Nephrol Dial Transplant; 2016 Jul; 31(7):1152-60. PubMed ID: 27235424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between vitamin D receptor activator and the risk of infection-related hospitalizations among incident hemodialysis patients: a nested case-control study.
    Normand I; Elftouh N; Laurin LP; Ouimet D; Harrak H; Lafrance JP
    Pharmacoepidemiol Drug Saf; 2014 Mar; 23(3):261-7. PubMed ID: 24470433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of VDRA on survival in incident hemodialysis patients: results of the FARO-2 observational study.
    Messa P; Cozzolino M; Brancaccio D; Cannella G; Malberti F; Costanzo AM; di Luzio Paparatti U; Festa V; Gualberti G; Mazzaferro S;
    BMC Nephrol; 2015 Feb; 16():11. PubMed ID: 25886515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between selection of dosage forms of vitamin D receptor activators and short-term survival of patients on hemodialysis.
    Koshi-Ito E; Inaguma D; Koide S; Takahashi K; Hayashi H; Tsuboi N; Hasegawa M; Maruyama S; Yuzawa Y
    Ren Fail; 2021 Dec; 43(1):1528-1538. PubMed ID: 34787531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible prevention of uremic nausea by vitamin D receptor activators in non-dialysis patients with stage 5 chronic kidney disease.
    Ikeda M; Ueda Y; Maruyama Y; Yokoyama K; Yokoo T; Joki N; Ando R; Shinoda T; Inaguma D; Yamaka T; Komatsu Y; Koiwa F; Sakaguchi T; Negi S; Shigematsu T
    Clin Exp Nephrol; 2017 Oct; 21(5):825-834. PubMed ID: 27844184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ability of vitamin D receptor activator to prevent pulmonary congestion in advanced chronic kidney disease.
    Sueta S; Morozumi K; Takeda A; Horike K; Otsuka Y; Shinjo H; Murata M; Kato Y; Goto K; Inaguma D;
    Clin Exp Nephrol; 2015 Jun; 19(3):371-8. PubMed ID: 24916005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predialysis Vitamin D Receptor Activator Treatment and Cardiovascular Events after Dialysis Initiation: A Multicenter Observational Study.
    Inaguma D; Tanaka A; Shinjo H; Kato A; Murata M;
    Nephron; 2016; 133(1):35-43. PubMed ID: 27054694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of vitamin D receptor activators on cardiovascular events in patients on hemodialysis-A post hoc analysis of the LANDMARK study.
    Yoshida K; Mizukami T; Fukagawa M; Akizawa T; Morohoshi H; Sambe T; Takeshima A; Ito H; Ogata H; Uchida N
    Ther Apher Dial; 2023 Jun; 27(3):523-529. PubMed ID: 36446713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D receptor agonist supplementation and suppression of inflammation may have advantage for all-cause mortality in hemodialysis patients.
    Ogawa T; Kyono A; Sato M; Sugimoto H; Otsuka K; Nitta K
    Clin Exp Nephrol; 2012 Oct; 16(5):779-85. PubMed ID: 22457088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH ≤ 150 pg/mL: results of the Italian FARO Survey.
    Cozzolino M; Brancaccio D; Cannella G; Messa P; Gesualdo L; Marangella M; LoDeserto C; Pozzato M; Rombolà G; Costanzo AM; di Luzio Paparatti U; Mazzaferro S;
    Nephrol Dial Transplant; 2012 Sep; 27(9):3588-94. PubMed ID: 22523119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance Status Modifies the Association Between Vitamin D Receptor Activator and Mortality or Fracture: A Prospective Cohort Study on the Japanese Society for Dialysis Therapy (JSDT) Renal Data Registry.
    Murashima M; Hamano T; Nishiyama T; Tsuruya K; Ogata S; Kanda E; Abe M; Masakane I; Nitta K
    J Bone Miner Res; 2022 Aug; 37(8):1489-1499. PubMed ID: 35689819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescription patterns and mineral metabolism abnormalities in the cinacalcet era: results from the MBD-5D study.
    Fukagawa M; Fukuma S; Onishi Y; Yamaguchi T; Hasegawa T; Akizawa T; Kurokawa K; Fukuhara S
    Clin J Am Soc Nephrol; 2012 Sep; 7(9):1473-80. PubMed ID: 22822017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal vitamin D supplementation during pregnancy and lactation to prevent acute respiratory infections in infancy in Dhaka, Bangladesh (MDARI trial): protocol for a prospective cohort study nested within a randomized controlled trial.
    Morris SK; Pell LG; Rahman MZ; Dimitris MC; Mahmud A; Islam MM; Ahmed T; Pullenayegum E; Kashem T; Shanta SS; Gubbay J; Papp E; Science M; Zlotkin S; Roth DE
    BMC Pregnancy Childbirth; 2016 Oct; 16(1):309. PubMed ID: 27737646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Dialysis Duration with Outcomes after Transplantation in a Japanese Cohort.
    Goto N; Okada M; Yamamoto T; Tsujita M; Hiramitsu T; Narumi S; Katayama A; Kobayashi T; Uchida K; Watarai Y
    Clin J Am Soc Nephrol; 2016 Mar; 11(3):497-504. PubMed ID: 26728589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ratio of paricalcitol dosage to serum parathyroid hormone level and survival in maintenance hemodialysis patients.
    Shinaberger CS; Kopple JD; Kovesdy CP; McAllister CJ; van Wyck D; Greenland S; Kalantar-Zadeh K
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1769-76. PubMed ID: 18701614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble Urokinase Plasminogen Activator Receptor and Outcomes in Patients with Diabetes on Hemodialysis.
    Drechsler C; Hayek SS; Wei C; Sever S; Genser B; Krane V; Meinitzer A; März W; Wanner C; Reiser J
    Clin J Am Soc Nephrol; 2017 Aug; 12(8):1265-1273. PubMed ID: 28495863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D supplementation for prevention of cancer in adults.
    Bjelakovic G; Gluud LL; Nikolova D; Whitfield K; Krstic G; Wetterslev J; Gluud C
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD007469. PubMed ID: 24953955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Oral Alfacalcidol on Clinical Outcomes in Patients Without Secondary Hyperparathyroidism Receiving Maintenance Hemodialysis: The J-DAVID Randomized Clinical Trial.
    ; Shoji T; Inaba M; Fukagawa M; Ando R; Emoto M; Fujii H; Fujimori A; Fukui M; Hase H; Hashimoto T; Hirakata H; Honda H; Hosoya T; Ikari Y; Inaguma D; Inoue T; Isaka Y; Iseki K; Ishimura E; Itami N; Ito C; Kakuta T; Kawai T; Kawanishi H; Kobayashi S; Kumagai J; Maekawa K; Masakane I; Minakuchi J; Mitsuiki K; Mizuguchi T; Morimoto S; Murohara T; Nakatani T; Negi S; Nishi S; Nishikawa M; Ogawa T; Ohta K; Ohtake T; Okamura M; Okuno S; Shigematsu T; Sugimoto T; Suzuki M; Tahara H; Takemoto Y; Tanaka K; Tominaga Y; Tsubakihara Y; Tsujimoto Y; Tsuruya K; Ueda S; Watanabe Y; Yamagata K; Yamakawa T; Yano S; Yokoyama K; Yorioka N; Yoshiyama M; Nishizawa Y
    JAMA; 2018 Dec; 320(22):2325-2334. PubMed ID: 30535217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular calcification in patients with nondialysis CKD over 3 years.
    Górriz JL; Molina P; Cerverón MJ; Vila R; Bover J; Nieto J; Barril G; Martínez-Castelao A; Fernández E; Escudero V; Piñera C; Adragao T; Navarro-Gonzalez JF; Molinero LM; Castro-Alonso C; Pallardó LM; Jamal SA
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):654-66. PubMed ID: 25770175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.